Consolidated statement of income

Continuing operations

Revenue

15,415

15,255

10,217

Cost of sales

(9,972)

(9,570)

(6,252)

Gross profit

5,443

5,685

3,965

Selling expenses

(3,294)

(3,177)

(2,230)

Impairment of ICI intangibles

(1,275)

–

–

General and administrative expenses

(1,074)

(1,126)

(654)

Research and development expenses

(353)

(359)

(282)

Other operating income/(expenses)

4

(73)

(44)

(52)

(6,069)

(4,706)

(3,218)

Operating income/(loss)

(626)

979

747

Financing income

5

154

282

157

Financing expenses

5

(337)

(370)

(277)

Results from associates and joint ventures

12

25

37

(20)

Profit/(loss) before tax

(784)

928

607

Income tax

6

(260)

(264)

(166)

Profit/(loss) for the period from continuing operations

(1,044)

664

441

Discontinued operations

Profit for the period from discontinued operations

7

23

–

8,920

Profit/(loss) for the period

(1,021)

664

9,361

Attributable to:

- Shareholders of the company

(1,086)

595

9,330

- Minority interests

65

69

31

Profit/(loss) for the period

(1,021)

664

9,361

Earnings per share, after incidentals in € 

17

Continuing operations:

- Basic

(4.47)

2.16

1.49

- Diluted

(4.45)

2.14

1.47

Discontinued operations:

- Basic

0.09

–

32.33

- Diluted

0.09

–

32.08

Total operations:

- Basic

(4.38)

2.16

33.82

- Diluted

(4.36)

2.14

33.55